Versant Venture Management as of March 31, 2016
Portfolio Holdings for Versant Venture Management
Versant Venture Management holds 7 positions in its portfolio as reported in the March 2016 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Glaukos (GKOS) | 38.2 | $53M | 3.1M | 16.86 | |
| Five Prime Therapeutics | 32.0 | $44M | 1.1M | 40.63 | |
| Ocular Therapeutix (OCUL) | 15.4 | $21M | 2.2M | 9.66 | |
| Clovis Oncology | 5.7 | $7.8M | 407k | 19.20 | |
| Biotie Therapies Corp. ads | 5.1 | $7.1M | 269k | 26.39 | |
| Achaogen | 2.5 | $3.5M | 1.3M | 2.76 | |
| Cymabay Therapeutics | 1.0 | $1.4M | 1.0M | 1.35 |
